Search

everythinglearnresearchcommunity

for

Search:↓

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Escin improves skin blood flow and health by enhancing blood vessel networks.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Baricitinib can cause excessive hair growth.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

A new therapy for a skin blistering condition has not been developed yet.

Potassium channel openers help form elastic fibers in arteries and can treat elastin deficiency and hypertension.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Tofacitinib is effective and safe for treating alopecia areata.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Using DNase enzymes to break down harmful NETs could be a new treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

Tofacitinib may effectively treat folliculitis decalvans.

Six existing drugs may help block virus entry in COVID-19.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

A new engineered treatment shows promise in curing heart fibrosis.